Jane Street’s Processa Pharmaceuticals PCSA Stock Holding History
Bought
Maintained
Sold
Other funds holding PCSA
Jane Street's PCSA Position: Q3 2026 in Review
Jane Street increased its Processa Pharmaceuticals (PCSA) stake by 2.3% in Q3 2026, buying an estimated $660 and bringing the position to 13,571 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #11266.
Jane Street first reported a position in PCSA in Q1 2023 and has held it in 5 quarters since. The position peaked at $86.9K in Q4 2025. 9 funds tracked by Wall St. Rank hold PCSA as of Q3 2026.
- Jane Street held 13,571 shares of Processa Pharmaceuticals worth $22.3K as of Q3 2026.
- Jane Street bought 307 Processa Pharmaceuticals shares in Q3 2026, an estimated $660.
- Processa Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #11266 holding.
- Jane Street first reported a position in Processa Pharmaceuticals in Q1 2023 and has held it in 5 quarters since.
- Jane Street's Processa Pharmaceuticals position peaked at $86.9K in Q4 2025.
- 9 funds tracked by Wall St. Rank held Processa Pharmaceuticals as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.